Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04157400 · ClinicalTrials.gov registry record · NA

Effect of Epidural Stimulation on Muscle Activation and Sensory Perception

A NA study, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
5
Enrollment target

NCT04157400: Completed NA study, sponsored by Medical University of South Carolina.

NCT04157400 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04157400, a NA study, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target

Study Summary

Each year, an estimated 34,000 individuals undergo epidural spinal cord stimulation (SCS) surgery to address debilitating chronic low back and leg pain (CLBLP). Although the commercial application of SCS to treat CLBLP was approved by the FDA in 1989, only in the past decade have significant advancements in stimulator technology been introduced. For instance, traditional SCS devices achieved reduction in pain using a type of stimulation known as low-frequency tonic stimulation (LFTS, below 100 Hz), which was dependent on induction of paresthesias (i.e., a tingling sensation) over the areas of pain perception. However, investigators now know that LFTS compromises sensory information flowing back to the spinal cord, which can be important in other spinal cord functions such as proprioception and movement. On the other hand, recent innovations in stimulator technology now provide the capability to apply stimulation frequencies up to 10,000 Hz along with complex waveform patterns - known as high frequency burst stimulation or HFBS - that can mitigate pain perception without the induction of paresthesias and the negative consequences on proprioception and movement. We propose to study the effects of these recently introduced features in SCS technology on motor and sensory spinal thresholds, proprioception and movement in subjects with CLBLP. The spinal cord relies on input from the motor cortex and surrounding extremities to initiate specific muscle recruitment, and recent evidence suggests that preservation of temporally specific proprioceptive information via dorsal column primary afferent fibers is critical for natural motor behaviors such as ambulation. Since the spinal cord is exposed during the placement of the SCS device, information about a subject's motor and sensory spinal pathways can be easily obtained during the regular course of the procedure and compared to proprioceptive and motor responses once the subject is awake and moving with the device turned on.

Primary Outcome

During intraoperative testing of varying stimulation parameters, the research team plans to collect evoked potentials via electromyography (EMG) as the primary outcome for step one. Evoked potential amplitude, recorded at specific muscles of interest, will be collected for nerve root activation threshold. The research team plans to look at musculature receiving innervation from varying levels of the spinal cord in order to determine any difference among stimulation type regarding nerve root isol

Interventions

  • DEVICE Intraoperative Parameter Testing
  • DEVICE Proprioception Testing During Stimulation
  • DEVICE Gait Analysis During Stimulation

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2019-11-26
Est. Completion 2021-11-01
Phase NA

What the finished NCT04157400 record still lists

NCT04157400 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 3 interventions - of which Intraoperative Parameter Testing is the first listed.

NCT04157400 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04157400 about?

NCT04157400 is a clinical study titled "Effect of Epidural Stimulation on Muscle Activation and Sensory Perception". Each year, an estimated 34,000 individuals undergo epidural spinal cord stimulation (SCS) surgery to address debilitating chronic low back and leg pain (CLBLP). Although the commercial application of SCS to treat CLBLP was approved by the FDA in 1989, only in the past decade have significant advance...

What is the current status of trial NCT04157400?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2019-11-26. Estimated completion is 2021-11-01.

What interventions are being tested in trial NCT04157400?

The interventions under investigation include: Intraoperative Parameter Testing (DEVICE), Proprioception Testing During Stimulation (DEVICE), Gait Analysis During Stimulation (DEVICE).

Who is sponsoring clinical trial NCT04157400?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04157400's enrollment target sits among peer trials

5 1988th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04157400, the US trial registry maintained by the National Library of Medicine. NCT04157400 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.